Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 6.54M P/E - EPS this Y 95.20% Ern Qtrly Grth -
Income -7.03M Forward P/E -1.00 EPS next Y 78.00% 50D Avg Chg -6.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -76.00%
Dividend N/A Price/Book 0.46 EPS next 5Y - 52W High Chg -96.00%
Recommedations 2.00 Quick Ratio 18.50 Shares Outstanding 1.77M 52W Low Chg 20.00%
Insider Own 0.39% ROA -55.99% Shares Float 278.82K Beta 2.45
Inst Own 4.55% ROE -92.31% Shares Shorted/Prior 35.45K/1.52K Price 0.30
Gross Margin - Profit Margin - Avg. Volume 725,469 Target Price 32.50
Oper. Margin - Earnings Date Mar 28 Volume 119,607 Change -3.88%
About Tenax Therapeutics, Inc.

Tenax Therapeutics, Inc. develops and commercializes pharmaceutical products containing imatinib for the treatment of pulmonary arterial hypertension. It develops TNX-101 (IV), TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension associated with heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is based in Chapel Hill, North Carolina.

Tenax Therapeutics, Inc. News
02/20/24 Tenax Therapeutics Announces Global License Amendment that Significantly Expands Rights to Levosimendan
02/12/24 TENX: First Patient Enrolled
02/08/24 Tenax Therapeutics Announces Pricing of Approximately $9 Million Public Offering
02/07/24 Tenax Therapeutics Enrolls First Patient in Phase 3 LEVEL Study Evaluating TNX-103 (Oral Levosimendan) for the Treatment of Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
02/06/24 Tenax Therapeutics Announces USPTO Grants Notice of Allowance for U.S. Patent Application, Significantly Broadening IP Protection for Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
01/03/24 Breakeven On The Horizon For Tenax Therapeutics, Inc. (NASDAQ:TENX)
12/29/23 Tenax Therapeutics Announces Reverse Stock Split
11/20/23 TENX: IND Clears Way for Phase III
11/17/23 Tenax Therapeutics Announces Professor Javed Butler, M.D., M.P.H, M.B.A., joins PH-HFpEF Scientific Advisory Board
11/13/23 Tenax Therapeutics Announces FDA Clearance of IND for TNX-103 (oral levosimendan) for the Treatment of Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF), Initiation of Phase 3 sites expected 2023
08/28/23 TENX: Second Quarter Results
08/25/23 7 F-Rated Biotech Stocks You Shouldn’t Touch With a 10-Foot Pole
07/19/23 Tenax Therapeutics Issued U.S. Patent for Oral Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
06/23/23 TENX: Notice of Allowance Increases Confidence
05/31/23 Tenax Therapeutics Achieves Major Milestone as USPTO Grants Notice of Allowance for U.S. Patent Application Covering Use of Oral Levosimendan (TNX-103) in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
05/22/23 TENX: Prioritizing Levosimendan
04/21/23 10 Stocks Targeted By Short Sellers Recently
04/12/23 Tenax Therapeutics Prioritizes Development Of TNX-103 For Heart Failure
04/12/23 Tenax Therapeutics Provides 2023 Business Update
04/05/23 TENX: Patents Guide the Way
TENX Chatroom

User Image gilheydari Posted - 14 hours ago

$TENX Did they do two offering back to back Jan30 @12 and raised 6M and then another one in Feb @5.63 and raised 9M??

User Image SmallSharkInBigPond Posted - 2 days ago

$TENX newsπŸ‘‡πŸ‘‡ https://www.sec.gov/Archives/edgar/data/34956/000165495424002134/tenx_8k.htm

User Image WatchD0G Posted - 2 days ago

$TENX Not cheap to short. -I'll wait you out.βœ”

User Image PapaFrancisco Posted - 2 days ago

$TENX The game here is a matter of HFs shorting the stock while the company's management trying to stay at Nasdaq. It doesn't cost anything for them to reverse split and dilute by pipe offering. At least keep their salaries up to date. It would be nice to see management buying the stock at least once.

User Image Ibrarex Posted - 3 days ago

$ICU $OCEA $ATOS $TENX

User Image TheLearnerEarner Posted - 3 days ago

After hours HOT list πŸ”₯ $BIOL $GRI $TENX $AIRE

User Image PugzNoDrugs Posted - 3 days ago

$TENX when reverse split?

User Image wilosmiles Posted - 3 days ago

$TENX no bottom on this bs

User Image WatchD0G Posted - 3 days ago

$TENX Undervalued. βœ” 1) Multiple 13G's (Insiders loading) 2) (2-20-23) Expanded Territory Rights To The Entire World 3) (2-20-23) Buy Rating w/PT: $30.00

User Image DavidUpla Posted - 3 days ago

$TENX $IOVA TENX

User Image Templar1000 Posted - 4 days ago

$TENX As mentioned before, this wants to reverse out. Slowly finding bottom and immense upside potential

User Image bubsomatic Posted - 4 days ago

$TENX still holding. Not sure why

User Image leo__25 Posted - 4 days ago

$LGHL Fair value by yahoo finance is 18$ Looking good for squeeze Also this: $MLGO $TOP $JMIA $TENX 🀞🀞🀞

User Image Shortshatepeople Posted - 4 days ago

$TENX isn’t it funny when a toxic firm puts a pt on their own investment lmfao. How’d that $3 target do before split?

User Image TheLearnerEarner Posted - 4 days ago

POWER HOUR REPORT ⚑ $TENX (8%+ today) or $RAPT (45%+ today) could fly in after hours, be ready πŸš€

User Image TheLearnerEarner Posted - 4 days ago

$TENX added potential MILLIONAIRE MAKER stock swing trade - healthcare - micro cap - 1.5x relative volume - Roth MKM buy rating - gained over +300% 1 day in November - short to long term gains πŸ’Ž Rsi: 33.92 (oversold upwards momentum) πŸ“Š Price Target: $32.50 (714.54% above Price) 🌟 Range (12m) $3.77 - $64.40 πŸ’° NEWSDESK (last recent article) πŸ“° https://investorplace.com/2023/11/why-is-tenax-therapeutics-tenx-stock-up-300-today/

User Image tommycman Posted - 4 days ago

$TENX My synopsis: bullish divergence on STOCH ready for a bounce up very shortly! Consolidating an holding over VWAP an waiting on MACD to curl and flip in next hour. Looking for a PH high up over $4.40.

User Image leo__25 Posted - 4 days ago

$WIMI Nice moving $MLGO wimi is the parent stock, should moving $LGHL AI & China Stock, profitable 32M cash, 5M debt, arket cap 5M Looking amazing $TENX after offering Now 4.3$ and got target 30$ $TOP we saw the lowest price, from here need to bounce 🀞🀞🀞🀞🀞🀞🀞🀞

User Image Businesspro Posted - 4 days ago

$TENX πŸš€πŸš€πŸš€

User Image WatchD0G Posted - 4 days ago

$TENX You're short. I get it. Good luck to you.

User Image leo__25 Posted - 4 days ago

$LGHL $TENX $MLGO $TOP $MHUA Look at this!!!! Something cookingπŸ”₯πŸ”₯πŸ”₯πŸ”₯πŸ”₯

User Image momeymaker1 Posted - 4 days ago

$TENX let goo.

User Image PapaFrancisco Posted - 4 days ago

$TENX Global License Agreement doesn't do much for share price. They don't have enough money for P3 trial and general expenses. Their only concern is to stay at Nasdaq.

User Image RollingDollar Posted - 4 days ago

$TENX

User Image MrTicker Posted - 4 days ago

$TENX could see a delayed run based off yesterdays PR

User Image PapaFrancisco Posted - 4 days ago

$TENX It seems oversold now, therefore it is up today. However, it will bleed below $1 and the cycle of RS and offering will start all over again until they are done with P3 trial. Not a long trade now, but intraday only.

User Image leo__25 Posted - 4 days ago

$LGHL Told you uesterday $TENX will squeeze.. starting today! πŸ”₯πŸ”₯πŸ”₯πŸ”₯πŸ”₯πŸ”₯πŸ”₯πŸ”₯ Nexr: $MLGO $TOP $MHUA

User Image WatchD0G Posted - 4 days ago

$TENX Looking good. Waiting for the volume to kick in. βœ”

User Image LongBallBarn Posted - 4 days ago

$TENX

User Image PapaFrancisco Posted - 4 days ago

$TENX $0.375 before reverse split. It's a joke!

Analyst Ratings
Roth MKM Buy Feb 20, 24
Roth MKM Buy Nov 13, 23
Roth MKM Buy Mar 7, 23
HC Wainwright & Co. Buy Dec 29, 20
Ladenburg Thalmann Buy May 18, 17